meg tirrell is back with those meg, it's facebook but not for a good reason. >> no. to be the case facebook coming under fire again. aclu is accusing the social media giant of discrimination. the group claims facebook violated federal and state laws by excluding women from seeing certain job ads. facebook put out a statement saying there's no place for discrimination on facebook it is prohibited in our policies we look forward to defending our practices once we have an opportunity to review the complaint. >> this is crazy you think about it, it seems so basic that these things should not happen i wonder how much of it is really happening there or there's so much focus, a microscope on top of a company like facebook, that people are trying to find anything. >> there's a huge microscope on facebook right now i'm interested in learning more of the details, but it seems like women in professions typically dominated by men were not seeing those ads >> silicon valley has perhaps a bit of a reputation. >>> los angeles is on track to be the biggest u.s. city to ban the sale

the stock tumbling meg tirrell is with us this morning on "worldwide exchange." you see what i did there >> i did >> they have to face the music missed a beat. >> i missed a beat on that one too early. >> it's late >> wow >> if you don't sleep, it's late >> that's true let's talk about sonos its stock went on a romam rolle coaster ride yesterday it went up 13% then fell as much as 15% in extended hours after the maker of wireless home speakers reported a third quarter loss of $27 million, nearly double the loss sonos reported in the same quarter last year. revenues were down 6% from a year ago sales of wireless speakers rose 1%, but revenue from home theater speakers and components fell sonos is one of the first companies to make and market a home wireless system in a letter to shareholders, the ceo cited the timing of new product launches for the dip in revenue. he is focusing on growth from the upcoming holiday season and the expansion into japan sonos is still up more than 20% since its ipo on august 2nd. >> that's a stock we have to watch. maybe not the relea

. >>> good morning, i'm meg tirrell. blast for the past and it's modeled after the origin play station. it's the answer to nintendo's sm classic. sony's classic will debut at $100 and be preloaded with 100 games just in time for the holiday season. with your cnbc morning business report, i'm meg tirrell. >>> thanks, g. 5:55. the season of apple picking, ha, riumpkin fights. if a is just around that -- whoa, that's not molette. what that? >> it's a sloth. >> you have to warn us when you're going to start out with something like that. >> sylvia. >> good morning, sylvia. sh >> reporter: e's really nice. she's a beautiful sloth. we're in her home. rise and shine, everybody.we e at the leesburg animal. park it's pumpkin village time here. they have all kinds of animals. they have a whole big plan for you. this is one of the biggest fall festiva festival. weave pablo and tegu. we have kids who have just arrived to enjoy this fantastic expegoence. we're g to tell you all about it in the 6:00 hour of "news 4 today." quite a tong

for nightly business report, meg tirrell. >> coming up porsche's need for speed. s a sound porsche owners love revving up the karin and before going race. we take you to place where porsche owners are meeting for rent sports number 6. coming up on nightly business report. >>> porsche owner he is and fans for a this weekend festival celebrating the german auto brands 70th anesversary. it c as the luxury brand enjoying record sales in the u.s. phil lebeau is in salinas, california, where the snd and speed of porsche is on display. >> reporter: it's music to the ears of porsche fans. the roar of porsche race cars turning lap after lap at the famed laguna racetrack. this is porsche's sixth reunion, the four-day celebration celebrating the feel and handling of pushing a performance car to thet,li in self-driving car, the people still here want to control the driving exsrience. >> i homecoming for an aspect of porsche, which is racing, which is the company's whole heritage. and every porsche race car is represented here. >> is kind of a slogan. but it's -- porsche -- it

. >> good morning, i'm meg tirrell at cnbcrs headquar sony is betting on a blast from the past.th ere'sstylein gam classic. it's the answer to nintendo's classic which debuted in 2017. sony's classic will debut in december at100 and come pre-loaded with 100 games in time of the for thely day season. >>> time to get up on your wedngeday morning. the day started. that means we'll take the dog for a walk. here's a dog for adoption. here's peach. sweetheart of a girl. good day to take peach or any pooch out for a walktoday. temperatures in the 80s by later on this afternoon. >>> and right nowan new problem on the inner loop near 50. vehicle on its side. vehicle on its side. full d i'm neal simon. i'm the son of an immigrant and a familyan. daughter: hey, dad. neal: and now i'm running fothe u.s. senate, unaffiliated with any party, because they're playing partisan games and gettthing done, and it's crippling america. i've created high-paying jobs right here in maryland by listening, bringing peopltogether, and finding common ground, and i'll do the same thing as your senator. they say an ou

meg tirrell has the exciting details. >> it is a huge result for the fortunes of amarin as well as foroptions for treating heart disease the number one cause of death in the united states and worldwide. amarin's drug vascepa is already approved to lower a type of fat in the blood sales last year were 1$180 million modest when compared to lipitor. new clinical trial results today so he vascepa reduce heart attack or stroke by 25% when given on top of statins. that's more than wall street was expecting which is reflected in the stock price today. the drug is derived from fish oil but it is a highly purified of the omega free acid known as e.p.a. some doctors still have questions about the result which will be presented more fully in november, but john boris of sun trust says he sees a market of the drug of more than 30 million patients >> will this news be a game changer for heart patients let's bring in john thero, the president of amarin. >> happy to be here. i hope these results help millions of patients >> when you look at preventing risks, heart risks, you know, your results, 25% re

. >>> shares of gw farm pharma mo higher first let's get more on today's news from our own meg tirrell. >> that's right. the drug enforcement administration has rescheduled the first drug derived from the cannabis plant it doesn't apply to all marijuana. it's a specific decision about the recent medicine epidialex. marijuana is a schedule one substance. that's the strictest category. the drugs have no currently acceptable use heroin and lsd are also in that category epidialex doesn't contain all of that, just the cbd it's not associated with the highs of thc this puts epidialex in segment 5. >> a lot of drug companies presumably are watching this closely for what this could mean for their potential drugs. >> yeah, it was a question would this be a broader application for all cbd, could it affect marijuana. this is pretty narrow. >> with us is justin glover. great to see you again >> thank you for having me back on the show. you know, a lot of analysts are saying this is the best possible outcome for you and they're anticipating a u.s. launch of the drug in six weeks. it seems like you'

m meg tirrell explains. >> reporter: a drug on the market suddenly sees a price increase of 400%, a generictic manufactured by a company called nostrum, a story familiar to martin shkreli that prompted a response from none other than the fda commissioner who wrote on twitter, quote, there's no moral imperative to price gauge and take advantage of patients i just spoke with nostrum's ceo saying he's been misrepresented. he increased the price of the drug to $2,400 a bottle but he says that's not the price he expects to collect on the drugs after significant discounts negotiated by his customers, like walmart and walgreens and his company has operated at a loss for eight of the 11 years it's been in business so when he can make money on a product he does so to support the rest of the business further, he's added a discount to the branded version which costs $2,800 a bottle. this is just one of 60 products that got price increases, most from smaller manufacturers the ceo says the dynamics are a result of theinefficiencies at the fda, skyrocketing fees and uncertainty about the marketplace. man

. >> we've got an earnings alert on bed bath & beyond meg tirrell with the numbers. >> looks like a biger and the stock is reacting that way on earnings coming in at 36 cents a share versus estimates of 50 cents a share. revenue coming in at 2.94 billion versus analyst average average of $2.96 billion a miss on comparable store sales. they declined by 0.6% versus an expectation of growth of 0.3%. the company revising its outlook for the year saying it sees comparable store sales flat for the year previously they had seen growth in the low digit percentage range and say the earnings per share is going to be at the low end of the forecast around $2 a share there. however, they do say at the end of this release they are still on track to grow earnings per share by 2020. that stock down 15% after a 14% drop year-to-date before this drop after hours, guys back to you. >> meg, thanks so much for that. mike, clearly same-store sales disappointing. the earnings very poor. >> what they had to say about the holiday quarter, which is not encouraging. the stock over two years down more than 40%. if